TD Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-80,300
Closed -$1.54M 1361
2024
Q3
$1.54M Buy
80,300
+45,100
+128% +$935K ﹤0.01% 1109
2024
Q2
$729K Buy
+35,200
New +$700K ﹤0.01% 1214
2023
Q4
Sell
-55,545
Closed -$964K 1429
2023
Q3
$964K Sell
55,545
-900
-2% -$18.8K ﹤0.01% 1149
2023
Q2
$1.17M Buy
56,445
+26
+0% +$565 ﹤0.01% 1095
2023
Q1
$1.33M Buy
56,419
+9,055
+19% +$243K ﹤0.01% 1085
2022
Q4
$1.32M Sell
47,364
-1,033
-2% -$26.4K ﹤0.01% 1088
2022
Q3
$1.14M Buy
48,397
+544
+1% +$16.4K ﹤0.01% 1151
2022
Q2
$1.61M Sell
47,853
-6,846
-13% -$240K ﹤0.01% 1068
2022
Q1
$1.91M Buy
54,699
+7,574
+16% +$259K ﹤0.01% 1105
2021
Q4
$1.44M Sell
47,125
-20,966
-31% -$683K ﹤0.01% 1208
2021
Q3
$2.23M Buy
68,091
+226
+0.3% +$7.23K ﹤0.01% 1055
2021
Q2
$1.97M Buy
+67,865
New +$2.23M ﹤0.01% 1102

Other funds holding OGN

TD Asset Management's OGN Position: Q4 2024 in Review

TD Asset Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 80,300 shares — an estimated $1.54M sold.

TD Asset Management first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $2.23M in Q3 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • TD Asset Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • TD Asset Management sold 80,300 Organon & Co shares in Q4 2024, an estimated $1.54M.
  • TD Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
  • TD Asset Management's Organon & Co position peaked at $2.23M in Q3 2021.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.